NIHR DC Discover

Latest important health research summarised

Man and talking, woman holding mans arm in support

NIHR Signal Peer support may reduce readmissions following mental health crises

People discharged from mental health crisis teams are less likely to re-enter acute services within a year if they receive self-management support. The support in this study was provided by a peer worker, someone with experience of mental illness. The peer worker used a workbook to provide information and talk through recovery goals. The study... Read More

  • 13 November 2018
  • Signal

Child having her ears looked at by a healthcare professional.

NIHR Signal Oral steroids do not help hearing for children with glue ear

Oral steroids do not improve hearing, symptoms, or quality of life in children with glue ear. This NIHR-funded trial compared oral steroids with placebo for 389 children with glue ear, also called otitis media with effusion, and found no significant effect on those outcomes.

Glue ear is when the middle ear fills with fluid, often following an... Read More

  • 13 November 2018
  • Signal

Man with artificial pancreas device attached to his abdomen.

NIHR Signal ‘Artificial pancreas’ improves glucose control in hospital patients with type 2 diabetes

Closed-loop insulin pumps, which continuously monitor blood glucose and administer insulin accordingly, can improve blood glucose control among patients with type 2 diabetes admitted to hospital for non-critical care. Those using the system spent about six hours longer in the target range, and this could hasten their recovery and reduce staff... Read More

  • 13 November 2018
  • Signal

Patient having abdominal ultrasound in hospital

NIHR Signal Abdominal aortic aneurysm screening for women is unlikely to be a fair use of NHS resources

Nearly 4,000 women would need screening to prevent one death, and a third of aneurysms detected wouldn’t have influenced the individual woman's health or lifespan.

Aneurysm rupture is a life-threatening emergency with low survival. Men are known to be at higher risk of an aneurysm and are offered screening at age 65 to allow early... Read More

  • 13 November 2018
  • Signal

Child undergoing chemotherapy treatment.

NIHR Signal Sodium thiosulfate reduces hearing loss in children treated with chemotherapy

Treatment with sodium thiosulfate alongside cisplatin chemotherapy can reduce hearing loss in children with a liver tumour called hepatoblastoma. The risk of hearing loss was reduced by 48% in children who had the combination treatment compared with those who had cisplatin only.

This phase 3 trial involved 109 children with standard-risk... Read More

  • 6 November 2018
  • Signal

Show more articles
Search Portal